Skip to content
Screener

Bausch Health Companies BHC Q2 2025 earnings

Reported July 30, 2025 · After market close

Revenue$2.5BMiss by $53.4M
EPS$0.90Miss by $0.07
Revenue estimate$2.6B
EPS estimate$0.97

Next report

Oct 28, 2026 (in a month)
Revenue estimate$2.8B
EPS estimate$1.19

Financials

Q2 2025

Income statement

See full
Revenue$2.5B+5.3%
Operating income$444.0M+14.1%
Net income$148.0M+1,380%
EPS (diluted)$0.40+1,233%

Balance sheet

See full
Cash & equivalents$1.7B+180%
Total debt$21.7B+0.4%
Total equity-$764.0M+35.0%
Total assets$27.3B+2.9%

Cash flow

See full
Operating cash flow$289.0M-23.9%
CapEx$99.0M+26.9%
Free cash flow$190.0M-37.1%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$2.29B-10.4%
Enterprise value$22.29B-5.5%
P/S0.2×0.0×

Profitability

See full
Operating margin16.2%+4.8pp
FCF margin11.3%+0.8pp

Returns & leverage

See full
Current ratio1.3×+0.1×

Segments

By segment

See full
Bausch + Lomb$1.3B+5.1%
Salix$627.0M+12.4%
International$278.0M+0.7%
Diversified$219.0M-12.7%
Solta Medical$128.0M+25.5%

FAQ

When did Bausch Health Companies report Q2 2025 earnings?
Bausch Health Companies (BHC) reported Q2 2025 earnings on July 30, 2025 after market close.
What were Bausch Health Companies's Q2 2025 revenue and EPS?
Bausch Health Companies reported revenue of $2.5B and eps of $0.90 for Q2 2025.
Did Bausch Health Companies beat estimates in Q2 2025?
Revenue missed the consensus estimate of $2.6B by $53.4M. EPS missed the consensus estimate of $0.97 by $0.07.
How did Bausch Health Companies's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 5.3% from $2.4B a year earlier and eps grew 1.1% from $0.89.
Where can I find Bausch Health Companies's Q2 2025 SEC filings?
You can read the 8-K earnings release (0001193125-25-167131) and the 10-Q periodic report (0000885590-25-000032) directly on SEC EDGAR. The filing index links above go to sec.gov.